BENJAMIN F. MCGRAW III

Insider Reports History

Location
Burlingame, CA
Signature
/s/ Gregory S. Moss, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by BENJAMIN F. MCGRAW III:

Company Role Class Num Shares Value Price $ Report Date Ownership
Evommune, Inc. Director Stock Option (Right to Buy) 37,960 05 Nov 2025 Direct
AERIE PHARMACEUTICALS INC Director Common Stock 0 $15.25 21 Nov 2022 Direct
AERIE PHARMACEUTICALS INC Director Stock Option (right to buy) 0 $9.14 21 Nov 2022 Direct

Insider Reports Filed by BENJAMIN F. MCGRAW III

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000121699425000008-mcgraw-benjamin-f-iii-2025-11-05 Evommune, Inc. 05 Nov 2025 1 $0 4 Director 07 Nov 2025, 16:15
/report/000121699425000006-mcgraw-benjamin-f-iii-2025-11-05 Evommune, Inc. 05 Nov 2025 0 $0 3 Director 05 Nov 2025, 20:07
/report/000120919122058189-mcgraw-benjamin-f-iii-2022-11-21 AERIE PHARMACEUTICALS INC 21 Nov 2022 4 -$1,184,573 4 Director 21 Nov 2022, 15:57
/report/000120919122036397-mcgraw-benjamin-f-iii-2022-06-09 AERIE PHARMACEUTICALS INC 09 Jun 2022 2 $0 4 Director 13 Jun 2022, 17:18
/report/000120919122014974-mcgraw-benjamin-f-iii-2022-02-28 AERIE PHARMACEUTICALS INC 28 Feb 2022 1 -$85,689 4 Interim Executive Chair, Director 02 Mar 2022, 16:38
/report/000120919121057288-mcgraw-benjamin-f-iii-2021-09-20 AERIE PHARMACEUTICALS INC 20 Sep 2021 2 $0 4 Interim Executive Chair, Director 22 Sep 2021, 17:40
/report/000120919121042031-mcgraw-benjamin-f-iii-2021-06-17 AERIE PHARMACEUTICALS INC 17 Jun 2021 2 $0 4 Director 21 Jun 2021, 16:36